7.9 Structure of various flavones compounds possesses cytotoxic potential...Figure 7.10 Structure of some flavonones compounds derived from medicinal plants...Figure 7.11 Mechanism of action of flavonoid on apoptotic pathway in cancer cell...8 Chapter 10Figure 10.1 Oral and dental health problems that used phytopharmaceutics.
9 Chapter 11Figure 11.1 Reactive oxygen species (ROS) production and endothelial dysfunction...Figure 11.2 Reactions and transformations of the superoxide anion by superoxide ...Figure 11.3 Endothelial dysfunction induced by hyperglycemia and role of the Nrf...Figure 11.4 Endothelial dysfunction by eNOS uncoupling. Nitric oxide (NO) is pro...Figure 11.5 Induction of endothelial dysfunction by inflammation. IL-1, TNF, oxi...Figure 11.6 Chemical structures of resveratrol, epigallocatechin gallate (EGCG),...Figure 11.7 Enhancing effects of resveratrol on nitric oxide production. Resvera...Figure 11.8 The anti-atherogenic effects of resveratrol. Resveratrol activates e...Figure 11.9 Induction of anti-inflammatory activity by epigallocatechin gallate ...Figure 11.10 Preventive effect of epigallocatechin gallate (EGCG) on endothelial...Figure 11.11 Antioxidant and anti-inflammatory effects of quercetin in human aor...
10 Chapter 12Figure 12.1 Quercetin—chemical structure.
11 Chapter 13Figure 13.1 Traditionally used Rubus species.
12 Chapter 14Figure 14.1 The bioactive compounds from brown algae.Figure 14.2 A summarized of some action mechanisms and targets of phlorotannins ...Figure 14.3 A diagram of the EMT generating cancer stem-like cells from cancer c...
13 Chapter 15Figure 15.1 Clinical signs of Polycystic Ovary Syndrome.Figure 15.2 Cinnamon. Personal file.Figure 15.3 Flax seeds. Personal file.Figure 15.4 Aloe vera. Personal file.Figure 15.5 Spearmint. Personal file.
14 Chapter 16Figure 16.1 (a–f) Findings from an analysis of NetPhos. Blue, green & red line i...Figure 16.2 (a–f) Signal-P data, shown in terms of C score, is raw site cleavage...Figure 16.3 (a–f) SOPMA Analytical Findings. The color lines blue, red, green an...Figure 16.4 (a–r) Molecular interaction between neurological disorder targeted p...Figure 16.5 (a–f) Molecular interaction between neurological disorder targeted p...
15 Chapter 17Figure 17.1 Chemical structurers of Endocannabinoids: (a) N-arachidonoyl ethanol...Figure 17.2 Cannabinoid receptors CB-1/2, contributes in several physiological f...Figure 17.3 Biosynthesis pathway of major cannabinoid Tetrahydrocannabinol and c...Figure 17.4 Different types of Cannabinoids: (a) Cannabidiol, (b) Delta-9-tetrah...
16 Chapter 20Figure 20.1 Schinus terebinthifolius Raddi.Figure 20.2 Search and selection results.Figure 20.3 Some major phenolic compounds of the species Schinus terebinthifoliu...Figure 20.4 Some major compounds from essential oil from different parts of the ...
17 Chapter 22Figure 22.1 Steroidal chemical constituents.Figure 22.2 Flavonoid C-glycoside.Figure 22.3 Flavones.Figure 22.4 Essential oil components.Figure 22.5 Tannins.Figure 22.6 Organic acid.Figure 22.7 Phenolic acids.Figure 22.8 Monoglyceride.Figure 22.9 Sesquiterpene.Figure 22.10 Diarylheptanoids.
Guide
1 Cover
5 Preface
7 Index
8 Also Available by the Same Editors
Pages
1 v
2 ii
3 iii
4 iv
5 xvii
6 xviii
7 xix
8 xx
9 1
10 2
11 3
12 4
13 5
14 6
15 7
16 8
17 9
18 10
19 11
20 12
21 13
22 14
